Koers Abattis Bioceuticals Corp. Other OTC
Aandelen
ATTBF
CA00258G1037
Gezondheidszorgvoorzieningen & -diensten
Omzet 2018 | 8,37K 6,08K 5,65K | Omzet 2019 | 357K 259K 241K | Marktkapitalisatie | 8,62 mln. 6,25 mln. 5,81 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -78 mln. -56,62 mln. -52,64 mln. | Nettowinst (verlies) 2019 | -3 mln. -2,18 mln. -2,02 mln. | EV/omzet 2018 | 5.778 x |
Nettoliquiditeiten 2018 | 9,1 mln. 6,6 mln. 6,14 mln. | Nettoliquiditeiten 2019 | 2,25 mln. 1,63 mln. 1,52 mln. | EV/omzet 2019 | 17,8 x |
K/w-verhouding 2018 |
-0,57
x | K/w-verhouding 2019 |
-2,8
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 99,64% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Director of Finance/CFO | - | 01-04-19 | |
Patrick Mitchell
COO | Chief Operating Officer | - | 01-11-18 |
Jonathan Danieli
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Cedric Wilson
BRD | Director/Board Member | - | 19-10-18 |
Patrick Mitchell
COO | Chief Operating Officer | - | 01-11-18 |
Director of Finance/CFO | - | 01-04-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+14,40% | 222 mln. | |
+2,06% | 211 mln. | |
+26,74% | 164 mln. | |
+300,00% | 121 mln. | |
-28,57% | 120 mln. | |
+26,09% | 114 mln. | |
+96,46% | 110 mln. | |
-53,09% | 98,07 mln. | |
-3,85% | 86,5 mln. |